Antibiotic Tablet in pharma franchise in India

Amoxycillin Tablets PCD pharma franchise in All Over India

Antibiotic Tablet in top pharma company in Pan India

Antibiotic Medicines PCD pharma Franchise in all states of India

Antibiotic Tablet Franchise Manufactured by AKUMS
Why Amoxiclav with LB is a Bestselling Product

Home/Products /amoxycillin-500mg-clavulanic-acid-125mg-lactobacillus-60million-spores-tablet

Moxyplit CV 625 LB Tablet

Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*1*10

Price : ₹262/-

Moxyplit CV 625 LB containing Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus Tablets represents a highly sought-after and modern solution in the Indian antibiotic market. This combination is a strategic addition to any PCD pharma franchise or B2B pharma business.This unique selling point makes it a premium and highly desirable product for doctors and end-users, ensuring strong demand and repeat sales for our pharma distributors.

By partnering with Cafoli Lifecare, you're not just getting a product; you're getting a bestselling antibiotic with a built-in advantage. We offer this high-quality formulation at competitive rates, ensuring you have the best product to resell at a profitable margin. This is an ideal product for those seeking a profitable PCD franchise with a product that stands out in the market.

Moxyplit CV 625 LB Tablet is primarily used to treat infections such as respiratory tract infections (e.g., pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Its dual action makes it an effective option for patients needing both antibiotic therapy and support for digestive health during treatment.

Read More

About the Product

Moxyplit CV 625 LB containing Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus Tablets represents a highly sought-after and modern solution in the Indian antibiotic market. This combination is a strategic addition to any PCD pharma franchise or B2B pharma business.This unique selling point makes it a premium and highly desirable product for doctors and end-users, ensuring strong demand and repeat sales for our pharma distributors.

By partnering with Cafoli Lifecare, you're not just getting a product; you're getting a bestselling antibiotic with a built-in advantage. We offer this high-quality formulation at competitive rates, ensuring you have the best product to resell at a profitable margin. This is an ideal product for those seeking a profitable PCD franchise with a product that stands out in the market.

Moxyplit CV 625 LB Tablet is primarily used to treat infections such as respiratory tract infections (e.g., pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Its dual action makes it an effective option for patients needing both antibiotic therapy and support for digestive health during treatment.

Common side effects may include nausea, vomiting, diarrhea, or indigestion. If these side effects become severe, contact your doctor promptly.

Moxyplit CV 625 LB Tablet Treats bacterial infections while preventing antibiotic-associated diarrhea; effective in respiratory, urinary, skin, and soft tissue infections.

Information regarding the use of Moxyplit CV 625 Tablet during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation